| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 From the Department of Ophthalmology, Kansai Medical University, Osaka, Japan; and the 2 Department of Pharmaceutical Sciences, University of Missouri, Kansas City, Missouri.
PURPOSE. Pigment epithelium-derived factor (PEDF) is a protein produced by the retinal pigment epithelial (RPE) cells. Recent studies have implicated PEDF in activities that are inhibitory to angiogenesis. In this study, the expression of PEDF was investigated in normal rat eyes and in eyes with experimentally induced choroidal neovascularization and compared with the expression of vascular endothelial growth factor (VEGF).
METHODS. Choroidal neovascularization was induced by laser photocoagulation in rat eyes. At intervals of up to 2 weeks after photocoagulation, the eyes were removed and prepared for in situ hybridization and immunohistochemical study. In situ hybridization was performed with digoxigenin-labeled PEDF riboprobes. Protein expression of PEDF and VEGF was studied immunohistochemically.
RESULTS. In normal adult rat eyes, PEDF mRNA was observed mainly in the corneal epithelial and endothelial cells, lens epithelial cells, ciliary epithelial cells, retinal ganglion cells, and the RPE cells. During the development of choroidal neovascularization, PEDF mRNA, PEDF protein, and VEGF protein were strongly detected in many cells within the laser lesions at 3 days after photocoagulation, after which levels gradually declined. However, PEDF was still expressed in the RPE cells that proliferated and covered the neovascular tissues at 2 weeks, whereas VEGF protein was weakly expressed in endothelial cells in choroidal neovascularization.
CONCLUSIONS. PEDF is expressed in different cell types of normal rat eyes. The expression of PEDF was detected in the choroidal neovascular tissues induced by photocoagulation, and these findings suggest that PEDF may modulate the process of choroidal neovascularization.
This article has been cited by other articles:
|
|
 |
|
  I. A. Bhutto, K. Uno, C. Merges, L. Zhang, D. S. McLeod, and G. A. Lutty Reduction of Endogenous Angiogenesis Inhibitors in Bruch's Membrane of the Submacular Region in Eyes With Age-Related Macular Degeneration Arch Ophthalmol, May 1, 2008; 126(5): 670 - 678. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Steinle, S. Sharma, and V. C. Chin Normal Aging Involves Altered Expression of Growth Factors in the Rat Choroid J. Gerontol. A Biol. Sci. Med. Sci., February 1, 2008; 63(2): 135 - 140. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Mochimaru, N. Nagai, G. Hasegawa, C. Kudo-Saito, T. Yaguchi, Y. Usui, T. Kurihara, T. Koto, S. Satofuka, H. Shinoda, et al. Suppression of Choroidal Neovascularization by Dendritic Cell Vaccination Targeting VEGFR2 Invest. Ophthalmol. Vis. Sci., October 1, 2007; 48(10): 4795 - 4801. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Costa, R. Jorge, D. Calucci, J. A. Cardillo, L. A. S. Melo Jr, and I. U. Scott Intravitreal Bevacizumab for Choroidal Neovascularization Caused by AMD (IBeNA Study): Results of a Phase 1 Dose-Escalation Study. Invest. Ophthalmol. Vis. Sci., October 1, 2006; 47(10): 4569 - 4578. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Zamiri, S. Masli, J. W. Streilein, and A. W. Taylor Pigment epithelial growth factor suppresses inflammation by modulating macrophage activation. Invest. Ophthalmol. Vis. Sci., September 1, 2006; 47(9): 3912 - 3918. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Penn, G. W. McCollum, J. M. Barnett, X. Q. Werdich, K. A. Koepke, and V. S. Rajaratnam Angiostatic Effect of Penetrating Ocular Injury: Role of Pigment Epithelium-Derived Factor Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 405 - 414. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Strauss The Retinal Pigment Epithelium in Visual Function Physiol Rev, July 1, 2005; 85(3): 845 - 881. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Apte, R. A. Barreiro, E. Duh, O. Volpert, and T. A. Ferguson Stimulation of Neovascularization by the Anti-angiogenic Factor PEDF Invest. Ophthalmol. Vis. Sci., December 1, 2004; 45(12): 4491 - 4497. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Paskowitz, G. Nune, D. Yasumura, H. Yang, R. B. Bhisitkul, S. Sharma, M. T. Matthes, M. A. Zarbin, M. M. LaVail, and J. L. Duncan BDNF Reduces the Retinal Toxicity of Verteporfin Photodynamic Therapy Invest. Ophthalmol. Vis. Sci., November 1, 2004; 45(11): 4190 - 4196. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. P. Cosgrove, K. K. Brown, W. P. Schiemann, A. E. Serls, J. E. Parr, M. W. Geraci, M. I. Schwarz, C. D. Cool, and G. S. Worthen Pigment Epithelium-derived Factor in Idiopathic Pulmonary Fibrosis: A Role in Aberrant Angiogenesis Am. J. Respir. Crit. Care Med., August 1, 2004; 170(3): 242 - 251. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Matsuoka, N Ogata, T Otsuji, T Nishimura, K Takahashi, and M Matsumura Expression of pigment epithelium derived factor and vascular endothelial growth factor in choroidal neovascular membranes and polypoidal choroidal vasculopathy Br. J. Ophthalmol., June 1, 2004; 88(6): 809 - 815. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Cursiefen, S. Masli, T. F. Ng, M. R. Dana, P. Bornstein, J. Lawler, and J. W. Streilein Roles of Thrombospondin-1 and -2 in Regulating Corneal and Iris Angiogenesis Invest. Ophthalmol. Vis. Sci., April 1, 2004; 45(4): 1117 - 1124. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. K. Chan, L. N. Pham, C. Chinn, C. Spee, S. J. Ryan, R. J. Akhurst, and D. R. Hinton Mouse Strain-Dependent Heterogeneity of Resting Limbal Vasculature Invest. Ophthalmol. Vis. Sci., February 1, 2004; 45(2): 441 - 447. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. N. Frank Diabetic Retinopathy N. Engl. J. Med., January 1, 2004; 350(1): 48 - 58. [Full Text] [PDF]
|
|
|
|
|
|
U. Schmidt-Erfurth, U. Schlotzer-Schrehard, C. Cursiefen, S. Michels, A. Beckendorf, and G. O. H. Naumann Influence of Photodynamic Therapy on Expression of Vascular Endothelial Growth Factor (VEGF), VEGF Receptor 3, and Pigment Epithelium-Derived Factor Invest. Ophthalmol. Vis. Sci., October 1, 2003; 44(10): 4473 - 4480. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Oshima, C. Shukunami, J. Honda, K. Nishida, F. Tashiro, J.-i. Miyazaki, Y. Hiraki, and Y. Tano Expression and Localization of Tenomodulin, a Transmembrane Type Chondromodulin-I-Related Angiogenesis Inhibitor, in Mouse Eyes Invest. Ophthalmol. Vis. Sci., May 1, 2003; 44(5): 1814 - 1823. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Wilson, B. G. Hobbs, W.-Y. Shen, T. P. Speed, U. Schmidt, C. G. Begley, and P. E. Rakoczy Argon Laser Photocoagulation-Induced Modification of Gene Expression in the Retina Invest. Ophthalmol. Vis. Sci., April 1, 2003; 44(4): 1426 - 1434. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Guan, H-F Yam, B Su, K-P Chan, C-P Pang, W-W Liu, W-Z Zhang, and Y Lu Loss of pigment epithelium derived factor expression in glioma progression J. Clin. Pathol., April 1, 2003; 56(4): 277 - 282. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
